Anxiety disorders are associated with quality of life impairment in patients with insulin-dependent type 2 diabetes: a case-control study

dos Santos, Maria Augusta B.; Ceretta, Luciane B.; Réus, Gislaine Z.; Abelaira, Helena M.; Jornada, Luciano K.; Schwalm, Mágada T.; Neotti, Morgana V.; Tomazzi, Cristiane D.; Gulbis, Karina G.; Ceretta, Renan A.; Quevedo, João

doi:10.1590/1516-4446-2013-1230

Acessibilidade / Reportar erro

Brasil

Brazilian Journal of Psychiatry

Español English

Brasil

Español English

sumário « anterior atual seguinte »

Sumário

ORIGINAL ARTICLES • Rev. Bras. Psiquiatr. 36 (4) • Oct-Dec 2014 • https://doi.org/10.1590/1516-4446-2013-1230 copy

This erratum corrects:

2014, volume 36, issue 4, pages 298-304

Anxiety disorders are associated with quality of life impairment in patients with insulin-dependent type 2 diabetes: a case-control study

Authorship SCIMAGO INSTITUTIONS RANKINGS

Objective:

To assess the presence of anxiety disorders and quality of life in patients with insulin-dependent type 2 diabetes.

Methods:

Case-control study of 996 patients with type 2 diabetes and 2,145 individuals without diabetes. The sole inclusion criterion for the case group was insulin-dependent type 2 diabetes. We compared the case and control groups for sociodemographic variables, laboratory and clinical data, and presence of anxiety disorders. Quality of life was evaluated using the WHOQOL-BREF instrument, and the prevalence of anxiety disorder was evaluated by the Mini International Neuropsychiatric Interview (MINI).

Results:

Patients with diabetes had a higher prevalence of generalized anxiety disorder, panic disorder, and obsessive-compulsive disorder. The presence of these disorders in combination with type 2 diabetes was associated with worse quality of life in the physical, social, psychological, and environmental domains.

Conclusions:

This study demonstrates the importance of diagnosing and treating anxiety disorders in patients with diabetes, so as to prevent more serious complications associated with these comorbidities.

Anxiety disorders; quality of life; diabetes; comorbidities

	Patients (%)(n=996)	Controls (%)(n=2,145)	p-value
Sex
Male	43.4	40.8	0.18
Female	56.6	59.2
Marital status
Partner	56.7	55.4	0.45
No partner	43.3	44.6
Educational attainment
< 8 years	55.1	55.3	0.89
≥ 9 years	44.9	44.7
Cholesterol, total
< 200 mg/dL	35.3	47.4	0.001^* * p < 0.005 for comparison between patients and controls, chi-square test.
≥ 200 mg/dL	64.7	52.6
Cholesterol, LDL
< 100 mg/dL	25.7	64.2	0.001^* * p < 0.005 for comparison between patients and controls, chi-square test.
≥ 100 mg/dL	74.3	35.8
Hypertension
Present	63.4	35.8	0.001^* * p < 0.005 for comparison between patients and controls, chi-square test.
Absent	36.6	64.2
AMI
Present	9.8	6.7	0.002^* * p < 0.005 for comparison between patients and controls, chi-square test.
Absent	90.2	93.3
CVA
Present	10.4	1.1	0.001^* * p < 0.005 for comparison between patients and controls, chi-square test.
Absent	89.6	98.9

	Patients (%)(n=996)	Controls (%)(n=2,145)	OR_adj	p-value
Generalized anxiety disorder	34.1	21.8	1.77	0.001^* * p < 0.005 for comparison between patients and controls.
Panic disorder	25.7	12.3	2.31	0.001^* * p < 0.005 for comparison between patients and controls.
Social phobia	18.8	15.4	1.13	0.273
Obsessive-compulsive disorder	3.2	6.9	2.47	0.001^* * p < 0.005 for comparison between patients and controls.

Associação Brasileira de Psiquiatria Rua Pedro de Toledo, 967 - casa 1, 04039-032 São Paulo SP Brazil, Tel.: +55 11 5081-6799, Fax: +55 11 3384-6799, Fax: +55 11 5579-6210 - São Paulo - SP - Brazil
E-mail: editorial@abp.org.br

Acompanhe os números deste periódico no seu leitor de RSS

[1] Correspondence: GislaineZ. Réus, Laboratório de Neurociências, Programa de Pós-Graduação em Ciências da Saúde, Unidade Acadêmica de Ciências da Saúde, Universidade do Extremo Sul Catarinense, CEP 88806-000, Criciúma, SC, Brazil. E-mail: gislainezilli@hotmail.com